Thought Leadership
Thought-provoking insights from an executive search perspective on the latest biopharma news, market shifts, and industry milestones.
The Integral Role of CDMOs for the Future of the U.S. Biopharma Industry
Disruptive biotech companies developing cell and gene therapies (CGT) and other precision medicines remain imperative for industry evolution, and specifically, Contract Development Manufacturing Organizations (CDMOs) and Contract Research Organizations (CROs) will play a critical role in the coming years.